Question 1

Does Viking Global Investors own BBIO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Viking Global Investors holds 9,949,219 shares of BBIO (Bridgebio Pharma), worth $741M.

Question 2

How many shares of BBIO does Viking Global Investors own?

Accepted Answer

As of its Q2 2026 13F, Viking Global Investors holds 9,949,219 shares of BBIO (Bridgebio Pharma).

Question 3

What is Viking Global Investors' BBIO position worth?

Accepted Answer

As of its Q2 2026 13F, Viking Global Investors' BBIO position is worth $741M.

Question 4

Is Viking Global Investors buying or selling BBIO?

Accepted Answer

In Q2 2026, Viking Global Investors reduced its BBIO position by 1,893,215 shares (-16.0%).

Question 5

When did Viking Global Investors first buy BBIO?

Accepted Answer

Viking Global Investors first reported BBIO in its Q2 2019 13F and has listed it in 29 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	9.9M	-16.0%	$741M	2.1%	$74.48	0
2026-Q1	Decreased	11.8M	-17.7%	$879.4M	2.5%	$74.26	0
2025-Q4	Decreased	14.4M	-9.9%	$1.1B	2.9%	$76.49	0
2025-Q3	Decreased	16M	-13.9%	$829.9M	2.2%	$51.94	0
2025-Q2	Decreased	18.6M	-15.9%	$801.2M	2.3%	$43.18	0
2025-Q1	Decreased	22.1M	-12.2%	$762.5M	2.4%	$34.57	0
2024-Q4	Unchanged	25.1M	0.0%	$689.3M	2.2%	$27.44	0
2024-Q3	Unchanged	25.1M	0.0%	$639.6M	2.3%	$25.46	0
2024-Q2	Unchanged	25.1M	0.0%	$636.3M	2.4%	$25.33	0
2024-Q1	Unchanged	25.1M	0.0%	$776.7M	2.9%	$30.92	0
2023-Q4	Unchanged	25.1M	0.0%	$1B	3.7%	$40.37	0
2023-Q3	Decreased	25.1M	-5.6%	$662.4M	2.7%	$26.37	0
2023-Q2	Unchanged	26.6M	0.0%	$457.9M	1.9%	$17.20	0
2023-Q1	Unchanged	26.6M	0.0%	$441.4M	2.1%	$16.58	0
2022-Q4	Unchanged	26.6M	0.0%	$202.9M	1.0%	$7.62	0
2022-Q3	Unchanged	26.6M	0.0%	$264.6M	1.2%	$9.94	0
2022-Q2	Unchanged	26.6M	0.0%	$241.7M	1.1%	$9.08	0
2022-Q1	Unchanged	26.6M	0.0%	$270.2M	1.1%	$10.15	0
2021-Q4	Unchanged	26.6M	0.0%	$444M	1.3%	$16.68	0
2021-Q3	Unchanged	26.6M	0.0%	$1.2B	3.4%	$46.87	0
2021-Q2	Unchanged	26.6M	0.0%	$1.6B	4.9%	$60.96	0
2021-Q1	Unchanged	26.6M	0.0%	$1.6B	4.9%	$61.60	0
2020-Q4	Unchanged	26.6M	0.0%	$1.9B	5.2%	$71.11	0
2020-Q3	Unchanged	26.6M	0.0%	$998.8M	3.6%	$37.52	0
2020-Q2	Unchanged	26.6M	0.0%	$868.1M	3.8%	$32.61	0
2020-Q1	Unchanged	26.6M	0.0%	$772M	4.0%	$29.00	0
2019-Q4	Unchanged	26.6M	0.0%	$933.1M	4.4%	$35.05	0
2019-Q3	Unchanged	26.6M	0.0%	$571.6M	3.0%	$21.47	0
2019-Q2	New	26.6M	-	$718M	3.2%	$26.97	88

BBIO29 quarters

BBIO
29 quarters